WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:

PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events

Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches

Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production

Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
Milner Therapeutics Symposium 2025
-
ON Helix 2025: New Horizons for Bio Innovation
-
OBN BioTuesday
-
LSX USA Congress
Zyme Communications celebrates 15 years of providing specialist support for the life science sector
Cambridge and Manchester, UK, 25 June 2025: Zyme Communications Ltd. (Zyme), the life science specialist PR and marketing agency, today celebrates its 15-year anniversary, and introduces refreshed branding to reflect [...]
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer’s drug discovery
Enhanced Genomics’ 3D multi-omics platform harnessed to rapidly identify multiple novel therapeutic targets that were undetectable using conventional genomic approaches Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug [...]
OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics
Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and [...]